A Study to Assess the Effectiveness of Certolizumab Pegol in Patients With Axial Spondyloarthritis in Daily Life

Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis

NCT00717236 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess Disease Activity in Adult Participants With Axial Spondyloarthritis Who Receive Upadacitinib in a Real-world Setting

NCT05094128 ·Status: RECRUITING

Observation of Treatment With Certolizumab Pegol in Daily Practice

NCT01069419 ·Status: COMPLETED

A Placebo Controlled Study to Assess Efficacy and Safety of Certolizumab Pegol in the Treatment of Rheumatoid Arthritis

NCT00152386 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Long Term Safety and Efficacy of Bimekizumab in Subjects With Ankylosing Spondylitis

NCT03355573 ·Status: COMPLETED ·Phase: PHASE2

Axial Involvement in Psoriatic Arthritis Cohort

NCT04434885 ·Status: UNKNOWN

Ustekinumab for the Treatment of Patients With Active Ankylosing Spondylitis

NCT01330901 ·Status: COMPLETED ·Phase: PHASE2

Rheumatoid Arthritis (RA) Moderate to Low Disease Activity Study

NCT00674362 ·Status: COMPLETED ·Phase: PHASE3

Certolizumab Pegol in Subjects With Adult Onset Active and Progressive Psoriatic Arthritis

NCT01087788 ·Status: COMPLETED ·Phase: PHASE3

Initial Standardized Global Review in Axial Spondyloarthritis

NCT07141017 ·Status: RECRUITING ·Phase: NA

A Study of Brodalumab in Subjects With Axial Spondyloarthritis (axSpA)

NCT02985983 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate Efficacy and Safety of Upadacitinib in Adults With Axial Spondyloarthritis

NCT04169373 ·Status: COMPLETED ·Phase: PHASE3

Study to Demonstrate the Efficacy, Safety and Tolerability of an Intravenous Regimen of Secukinumab Compared to Placebo in Subjects With Active axSpA

NCT04156620 ·Status: COMPLETED ·Phase: PHASE3

A Study of Ixekizumab (LY2439821) in Participants With Nonradiographic Axial Spondyloarthritis

NCT02757352 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Tofacitinib in Subjects With Active Ankylosing Spondylitis (AS)

NCT03502616 ·Status: COMPLETED ·Phase: PHASE3

Open Label Extension for Patients Coming From the Dosing Flexibility Study in Patients With Rheumatoid Arthritis (RA)

NCT00753454 ·Status: COMPLETED ·Phase: PHASE3

Magnetic Resonance Image Verified Early Response to Certolizumab Pegol in Subjects With Active Rheumatoid Arthritis (RA)

NCT01235598 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Subjects With Active Nonradiographic Axial Spondyloarthritis

NCT03928704 ·Status: COMPLETED ·Phase: PHASE3

An Efficacy and Safety Study of Ustekinumab in Participants With Active Nonradiographic Axial Spondyloarthritis

NCT02407223 ·Status: TERMINATED ·Phase: PHASE3

A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis

NCT01521923 ·Status: COMPLETED ·Phase: PHASE3

Rotation or Change of Biotherapy After TNF Blocker Treatment Failure for Axial Spondyloarthritis

NCT03445845 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNFα Naive Participants With Active Radiographic Axial Spondyloarthritis

NCT02437162 ·Status: TERMINATED ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of Different Doses of Bimekizumab in Subjects With Active Ankylosing Spondylitis

NCT02963506 ·Status: COMPLETED ·Phase: PHASE2

Novel MRI ANd Biomarkers in GOlimumab-treated Patients With Axial Spondyloarthritis

NCT02011386 ·Status: COMPLETED

A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis

NCT01519791 ·Status: COMPLETED ·Phase: PHASE3